The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening

Sims, 2005, Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes, Diabetes Care, 28, 1581, 10.2337/diacare.28.7.1581 Lewis, 2015, Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex, Am J Respir Crit Care Med, 191, 194, 10.1164/rccm.201403-0576OC Godbout, 2008, No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes, Diabetes Metab, 34, 568, 10.1016/j.diabet.2008.05.010 Moran, 2010, Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, 33, 2697, 10.2337/dc10-1768 Abdulhamid, 2015, Improving screening for diabetes in cystic fibrosis, Int J Health Care Qual Assur, 28, 441, 10.1108/IJHCQA-05-2014-0059 Boudreau, 2016, Screening for cystic fibrosis-related diabetes: matching pathophysiology and addressing current challenges, Can J Diabetes, 40, 466, 10.1016/j.jcjd.2016.08.221 Gebhart, 1991, A comparison of home glucose monitoring with determinations of hemoglobin A1c, total glycated hemoglobin, fructosamine, and random serum glucose in diabetic patients, Arch Intern Med, 151, 1133, 10.1001/archinte.1991.00400060071012 Malmstrom, 2014, Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies — cross-sectional and longitudinal experience from the AMORIS cohort, PLoS One, 9, 10.1371/journal.pone.0111463 Lee, 2015, Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol, Ann Pediatr Endocrinol Metab, 20, 74, 10.6065/apem.2015.20.2.74 Garlick, 1983, The principal site of nonenzymatic glycosylation of human serum albumin in vivo, J Biol Chem, 258, 6142, 10.1016/S0021-9258(18)32384-6 Yoshiuchi, 2008, Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes, Endocr J, 55, 503, 10.1507/endocrj.K07E-089 Boisvert, 2015, Analytical evaluation of the Siemens' fructosamine and the Exocell Glycaben assays, Clin Biochem, 48, 1023, 10.1016/j.clinbiochem.2015.07.086 Miller, 2005, Standardisation of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 Rodriguez-Segade, 2017, Corrected fructosamine improves both correlation with HbA1C and diagnostic performance, Clin Biochem, 50, 110, 10.1016/j.clinbiochem.2016.10.014 Burgess, 2016, HbA1c as a screening tool for cystic fibrosis related diabetes, J Cyst Fibros, 15, 251, 10.1016/j.jcf.2015.03.013 Boudreau, 2016, Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes, J Cyst Fibros, 15, 258, 10.1016/j.jcf.2016.02.005 Schnyder, 2016, HbA1c: an effective screening tool for cystic fibrosis related diabetes?, J Cyst Fibros, 15, 261, 10.1016/j.jcf.2015.10.010 Widger, 2016, Using HbA1c as a screening tool for cystic fibrosis related diabetes, J Cyst Fibros, 15, 263, 10.1016/j.jcf.2015.10.009 Brodsky, 2011, Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis, Diabetes Care, 34, 292, 10.2337/dc10-1604 Coriati, 2016, The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis, Acta Diabetol, 53, 359, 10.1007/s00592-015-0791-3